Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Killedar, Smruti ^a,b   DiRosario, Julianne ^a   Divers, Erin ^a   Popovich, Phillip G ^b   McCarty, Douglas M ^a,b   Fu, Haiyan ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; IMMUNOGENETICS; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARALYSIS; SANFILIPPO SYNDROME; T LYMPHOCYTE ACTIVATION; WEIGHT GAIN; WILD TYPE; ADOPTIVE TRANSFER; ANIMAL; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CYTOLOGY; GENETICS; HISTOLOGY; HUMAN; IMMUNOLOGY; LYMPHOCYTE; MOLECULAR GENETICS; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; ROTAROD TEST; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUCOPOLYSACCHARIDOSIS III; ROTAROD PERFORMANCE TEST; SPLEEN;

EID: 77954550206     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-39     Document Type: Article

References (38)

1. Neufeld EF, Muenzer J. The mucopolysaccharidoses. The metabolic & molecular basis of inherited disease 2001, 3421-3452. New York; St Louis; San Francisco: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, 8.
2. Li HH, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S, Fanselow MS, Suzuki K, Vanier MT, Neufeld EF. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 1999, 96:14505-14510. 10.1073/pnas.96.25.14505, 24466, 10588735.
3. McGlynn R, Dobrenis K, Walkley SU. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 2004, 480:415-426. 10.1002/cne.20355, 15558784.
4. Ryazantsev S, Yu WH, Zhao HZ, Neufeld EF, Ohmi K. Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. Mol Genet Metab 2007, 90:393-401. 10.1016/j.ymgme.2006.11.006, 1892176, 17185018.
5. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 2003, 100:1902-1907. 10.1073/pnas.252784899, 149931, 12576554.
6. Li HH, Zhao HZ, Neufeld EF, Cai Y, Gomez-Pinilla F. Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J Neurosci Res 2002, 69:30-38. 10.1002/jnr.10278, 12111813.
7. Villani GR, Gargiulo N, Faraonio R, Castaldo S, Gonzalez YRE, Di Natale P. Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 2007, 85:612-622. 10.1002/jnr.21134, 17139681.
8. DiRosario J, Divers E, Wang C, Etter J, Charrier A, Jukkola P, Auer H, Best V, Newsom DL, McCarty DM, Fu H. Innate and adaptive immune activation in the brain of MPS IIIB mouse model. J Neurosci Res 2009, 87:978-990. 10.1002/jnr.21912, 18951493.
9. Villani GR, Di Domenico C, Musella A, Cecere F, Di Napoli D, Di Natale P. Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis. Brain Res 2009, 1279:99-108. 10.1016/j.brainres.2009.03.071, 19409882.
10. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. Faseb J 2006, 20:9-22. 10.1096/fj.05-4682rev, 16394262.
11. Silverman B, Cawston TE, Page Thomas DP, Dingle JT, Hazleman BL. The sulphated glycosaminoglycan levels in synovial fluid aspirates in patients with acute and chronic joint disease. Br J Rheumatol 1990, 29:340-344. 10.1093/rheumatology/29.5.340, 2224401.
12. Wang JY, Roehrl MH. Glycosaminoglycans are a potential cause of rheumatoid arthritis. Proc Natl Acad Sci USA 2002, 99:14362-14367. 10.1073/pnas.222536599, 137889, 12391302.
13. Dimitriu-Bona A, Fillit H. Studies of the cellular immune response to heparan sulfate proteoglycan in the tight skin mouse. Cell Immunol 1993, 150:321-332. 10.1006/cimm.1993.1200, 8370075.
14. Dimitriu-Bona A, Matic M, Ding W, Yang CP, Fillit H. Cytotoxicity to endothelial cells by sera from aged MRL/lpr/lpr mice is associated with autoimmunity to cell surface heparan sulfate. Clin Immunol Immunopathol 1995, 76:234-240. 10.1006/clin.1995.1121, 7554444.
15. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037. 10.1038/nature05817, 17460664.
16. Saadi S, Wrenshall LE, Platt JL. Regional manifestations and control of the immune system. Faseb J 2002, 16:849-856. 10.1096/fj.01-0690hyp, 12039867.
17. Wrenshall LE, Cerra FB, Carlson A, Bach FH, Platt JL. Regulation of murine splenocyte responses by heparan sulfate. J Immunol 1991, 147:455-459.
18. Wrenshall LE, Platt JL, Stevens ET, Wight TN, Miller JD. Propagation and control of T cell responses by heparan sulfate-bound IL-2. J Immunol 2003, 170:5470-5474.
19. Garner OB, Yamaguchi Y, Esko JD, Videm V. Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate. Immunology 2008, 125:420-429. 10.1111/j.1365-2567.2008.02856.x, 2669145, 18479348.
20. Dasgupta S, Zhou Y, Jana M, Banik NL, Pahan K. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps. J Immunol 2003, 170:3874-3882.
21. Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 1997, 90:895-905. 10.1016/S0092-8674(00)80354-2, 9298901.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4, 6606682.
23. Hodgkin PDHE, Hasbold J, Gett AV, Deenick EK, Todd HF, Hommel M. Monotoring T cell Proliferation 2005, Netherland: Springer.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
25. Gilat D, Cahalon L, Hershkoviz R, Lider O. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol Today 1996, 17:16-20. 10.1016/0167-5699(96)80563-9, 8652044.
26. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 1993, 14:500-505. 10.1016/0167-5699(93)90265-M, 8274190.
27. Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Platt JL. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J Immunol 2000, 165:1599-1604.
28. Popovich PG, Stokes BT, Whitacre CC. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res 1996, 45:349-363. 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9, 8872895.
29. Schroeter M, Jander S. T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Med 2005, 7:183-195. 10.1385/NMM:7:3:183, 16247179.
30. Krishnamoorthy G, Holz A, Wekerle H. Experimental models of spontaneous autoimmune disease in the central nervous system. J Mol Med 2007, 85:1161-1173. 10.1007/s00109-007-0218-x, 17569024.
31. Koller H, Siebler M, Hartung HP. Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Prog Neurobiol 1997, 52:1-26. 10.1016/S0301-0082(96)00065-2, 9185232.
32. Basso AS, Cheroutre H, Mucida D. More stories on Th17 cells. Cell Res 2009, 19:399-411. 10.1038/cr.2009.26, 2838708, 19255592.
33. Genain CP, Hauser SL. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 1997, 75:187-197. 10.1007/s001090050103, 9106075.
34. Tuohy VK, Sobel RA, Lees MB. Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J Immunol 1988, 140:1868-1873.
35. Benveniste EN. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 1997, 75:165-173. 10.1007/s001090050101, 9106073.
36. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994, 78:399-408. 10.1016/0092-8674(94)90419-7, 7520367.
37. Muhallab S, Lundberg C, Gielen AW, Lidman O, Svenningsson A, Piehl F, Olsson T. Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis. Scand J Immunol 2002, 55:264-273. 10.1046/j.0300-9475.2002.01038.x, 11940233.
38. Hammarberg H, Piehl F, Risling M, Cullheim S. Differential regulation of trophic factor receptor mRNAs in spinal motoneurons after sciatic nerve transection and ventral root avulsion in the rat. J Comp Neurol 2000, 426:587-601. 10.1002/1096-9861(20001030)426:4<587::AID-CNE7>3.0.CO;2-R, 11027401.